Trazimera (trastuzumab-qyyp) Injection, 420 mg/Vial, Powder for Reconstitution, Multi-Dose Vial
Trazimera is a sterile, preservative-free powder for reconstitution containing 420 mg of trastuzumab-qyyp, a HER2/neu receptor antagonist biosimilar to Herceptin. It is supplied as a multi-dose vial for intravenous infusion and is indicated for the treatment of HER2-overexpressing breast cancer and metastatic gastric cancer. Each vial is intended for single-patient use after reconstitution with bacteriostatic water for injection.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Trazimera is a sterile, preservative-free powder for reconstitution containing 420 mg of trastuzumab-qyyp, a HER2/neu receptor antagonist biosimilar to Herceptin. It is supplied as a multi-dose vial for intravenous infusion and is indicated for the treatment of HER2-overexpressing breast cancer and metastatic gastric cancer. Each vial is intended for single-patient use after reconstitution with bacteriostatic water for injection.
1 vendor
